Evidence map›Paper›PMID 42709784›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Antibodies targeting a shared epitope exploit IgE allostery to drive distinct functional outcomes.

Anna M Davies, Nyssa Drinkwater, Andrew J Beavil, Victoria O'Dowd, Daniel Lightwood, Tom Ceska, Alistair J Henry, Brian J Sutton, James M McDonnell

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna M DaviesRandall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, London SE1 1UL, United Kingdom.ORCID 0000-0003-1498-1594
Nyssa DrinkwaterRandall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, London SE1 1UL, United Kingdom.
Andrew J BeavilRandall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, London SE1 1UL, United Kingdom.ORCID 0000-0002-0768-122X
Victoria O'DowdUCB, Slough SL1 3WE, United Kingdom.
Daniel LightwoodUCB, Slough SL1 3WE, United Kingdom.
Tom CeskaUCB, Slough SL1 3WE, United Kingdom.ORCID 0000-0002-7200-9528
Alistair J HenryUCB, Slough SL1 3WE, United Kingdom.
Brian J SuttonRandall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, London SE1 1UL, United Kingdom.ORCID 0000-0002-4363-7568
James M McDonnellRandall Centre for Cell and Molecular Biophysics, King's College London, New Hunt's House, London SE1 1UL, United Kingdom.ORCID 0000-0001-9037-2980

Funding

UKRI | Medical Research Council (MRC) G1100090Wellcome Trust
6 · The paper itself

Abstract

The Fc region of immunoglobulin E (IgE-Fc) is an important therapeutic target due to the antibody's critical role in allergic disorders through interactions with high-affinity (FcεRI) and low-affinity (CD23) receptors. IgE-Fc is known to be conformationally flexible, undergoing large-scale structural changes that modulate receptor binding and downstream biological functions. The mechanistic basis for how ligands induce these allosteric changes is not fully understood. In this study, we investigate structure-function relationships of IgE by characterizing four closely related anti-IgE-Fc Fab fragments with highly conserved sequences that recognize a shared epitope at the base of the Cε2 domain. Despite their sequence similarity, these Fabs exhibit markedly different binding characteristics, stoichiometries, and functional activities. Furthermore, the crystal structures of these four Fab complexes reveal that the bound IgE-Fc adopts a wide range of conformations. These structural differences directly dictate the functional outcomes, ranging from conformations that facilitate FcεRI binding to those that prevent or destabilize receptor interaction. Our findings demonstrate that highly similar antibodies binding to the same epitope on a protein that exhibits significant conformational plasticity can elicit distinct and divergent functional outcomes. This work challenges the conventional antibody discovery paradigm, i.e., "same epitope, same functional outcome," and highlights the importance of accounting for both the target's structural flexibility and the resulting functional diversity within antibody selection strategies. This is especially critical when targeting dynamic proteins where allosteric mechanisms are fundamental to function.

Indexed as

EpitopesImmunoglobulin EAllosteric RegulationAnimalsCrystallography, X-RayHumansImmunoglobulin Fab FragmentsImmunoglobulin Fc FragmentsModels, MolecularProtein BindingProtein ConformationReceptors, IgEStructure-Activity RelationshipEpitopesImmunoglobulin EImmunoglobulin Fab FragmentsImmunoglobulin Fc FragmentsReceptors, IgEallosteric modulationantibody discoveryconformational plasticityimmunoglobulin Estructural immunology

Identifiers

PMID42709784
PMCPMC13578773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.